These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 7878822)

  • 1. Induction of transplantation tolerance by treatment with ICAM-1 antisense oligonucleotides and anti-LFA-1 monoclonal antibodies.
    Stepkowski SM; Tu Y; Condon TP; Bennett CF
    Transplant Proc; 1995 Feb; 27(1):113. PubMed ID: 7878822
    [No Abstract]   [Full Text] [Related]  

  • 2. Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities.
    Stepkowski SM; Tu Y; Condon TP; Bennett CF
    J Immunol; 1994 Dec; 153(11):5336-46. PubMed ID: 7963586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ICAM-1 and LFA-1 in a cardiac xenograft rejection model.
    Miwa S; Kawasaki S; Makuuchi M; Miyasaka M; Yamazaki S; Sekiguchi M; Isobe M
    Transplant Proc; 1995 Feb; 27(1):111-2. PubMed ID: 7878820
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation.
    Isobe M; Ihara A
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1079-80. PubMed ID: 8095106
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
    Isobe M; Suzuki J; Yamazaki S; Sekiguchi M
    Transplant Proc; 1996 Apr; 28(2):1045-6. PubMed ID: 8623222
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat.
    Komori A; Nagata M; Ochiai T; Nakajima K; Hori S; Asano T; Isono K; Tamatani T; Miyasaka M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):831-2. PubMed ID: 8094916
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of ICAM-1 antisense oligonucleotide in pancreatic islet transplantation.
    Katz SM; Browne B; Phan T; Wang ME; Bennett CF; Stepkowski SM; Kahan BD
    Transplant Proc; 1995 Dec; 27(6):3214. PubMed ID: 8539920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of accelerated coronary atherosclerosis with short-term blockade of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in a heterotopic murine model of heart transplantation.
    Suzuki J; Isobe M; Yamazaki S; Horie S; Okubo Y; Sekiguchi M
    J Heart Lung Transplant; 1997 Nov; 16(11):1141-8. PubMed ID: 9402514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
    J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine expression in cardiac allografts in mice with peripheral tolerance induced by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
    Suzuki J; Isobe M; Sekiguchi M; Maemura K; Nagai R; Yazaki Y
    Transplant Proc; 1995 Feb; 27(1):370-1. PubMed ID: 7879024
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of antibodies to leukocyte function-associated antigen-1 and intercellular adhesion molecule-1 on fetal bowel allo- and xenotransplantation in mice.
    Yamataka A; Kato Y; Fujiwara T; Yagita H; Okumura K; Sunagawa M; Nozawa M; Miyano T
    Transplant Proc; 1996 Oct; 28(5):2494-5. PubMed ID: 8907919
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4.
    Jendrisak M; Jendrisak G; Gamero J; Mohanakumar T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):825-7. PubMed ID: 8094914
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival.
    He Y; Mellon J; Apte R; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1994 Jul; 35(8):3218-25. PubMed ID: 7913917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts.
    Nakakura EK; McCabe SM; Zheng B; Shorthouse RA; Scheiner TM; Blank G; Jardieu PM; Morris RE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):809-12. PubMed ID: 8438493
    [No Abstract]   [Full Text] [Related]  

  • 15. [Selective immunosuppression with monoclonal antibodies against ICAM-1 and LFA-1 with FK 506 after experimental small intestine transplantation in the rat].
    Gasser M; Otto C; Timmermann W; Gassel HJ; Ulrichs K; Thiede A
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):595-9. PubMed ID: 14518324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
    Isobe M; Suzuki J; Yagita H; Okumura K; Sekiguchi M
    Transplant Proc; 1994 Apr; 26(2):867-8. PubMed ID: 7513478
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of corneal allograft rejection after penetrating keratoplasty by antibodies to ICAM-1 and LFA-1 in mice.
    Yamagami S; Obata H; Tsuru T; Isobe M
    Transplant Proc; 1995 Apr; 27(2):1899-900. PubMed ID: 7725542
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolongation of hepatic allograft survival with antibodies to ICAM-1 and LFA-1.
    Harihara Y; Sakamoto H; Sanjo K; Otsubo O; Watanabe G; Idezuki Y
    Transplant Proc; 1994 Aug; 26(4):2258. PubMed ID: 7915063
    [No Abstract]   [Full Text] [Related]  

  • 19. Difference in immunosuppressive effects of antibodies to ICAM-1 and LFA-1 between hepatic and cardiac allografts.
    Harihara Y; Sugawara Y; Inoue K; Kubota K; Bandai Y; Makuuchi M; Miyasaka M
    Transplant Proc; 1996 Jun; 28(3):1368-9. PubMed ID: 8658698
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.